Syngeneic fibrosarcoma mouse model | Human mammary carcinoma xenograft mouse model | |||||||
---|---|---|---|---|---|---|---|---|
Days | SPIL DXR HCl liposome injection 9 mg/kg | Reference DXR HCl liposome injection 9 mg/kg | SPIL DXR HCl liposome injection 1.5 mg/kg | Reference DXR HCl liposome injection 1.5 mg/kg | SPIL DXR HCl liposome injection 3 mg/kg | Reference DXR HCl liposome injection 3 mg/kg | SPIL DXR HCl liposome injection 6 mg/kg | Reference DXR HCl liposome injection 6 mg/kg |
%T/C (n) | %T/C (n) | %T/C (n) | %T/C (n) | %T/C (n) | %T/C (n) | %T/C (n) | %T/C (n) | |
0 | 98.26 (11) | 96.59 (15) ns | 109.73 (10) | 104.01 (10) ns | 121.01 (10) | 110.15 (10) ns | 106.77 (10) | 119.41 (10) ns |
3 | 95.85 (10) | 99.43 (10) ns | 105.52 (10) | 100.33 (10) ns | 90.24 (10) | 105.11 (10) ns | ||
7 | 41.83 (11) | 41.81 (15) ns | 99.89 (10) | 96.20 (10) ns | 92.40 (10) | 84.05 (10) ns | 73.89 (10) | 86.59 (10) ns |
10 | 101.32 (10) | 113.86 (10) ns | 80.23 (10) | 90.67 (10) ns | 57.70 (10) | 67.29 (10) ns | ||
14 | 11.07 (11) | 8.46 (15) ns | 96.73 (10) | 82.17 (10) ns | 56.76 (10) | 56.82 (10) ns | 27.63 (10) | 39.29 (10) ns |
17 | 82.60 (10) | 70.85 (10) ns | 50.36 (10) | 50.02 (10) ns | 18.47 (10) | 30.75 (10) ns | ||
21 | 2.56 (11) | 2.00 (15) ns | 77.17 (10) | 61.13 (10) ns | 33.51 (10) | 42.06 (10) ns | 13.80 (10) | 20.37 (10) ns |
24 | 77.12 (10) | 69.97 (10) ns | 33.53 (10) | 36.99 (10) ns | 14.29 (10) | 16.82 (10) ns | ||
28 | 0.48 (11) | 0.40 (14) ns | 71.72 (10) | 67.15 (10) ns | 35.25 (10) | 37.60 (10) ns | 12.90 (9) | 13.92 (9) ns |
31 | 70.05 (10) | 64.51 (10) ns | 27.48 (10) | 39.35 (10) ns | 10.64 (9) | 11.29 (9) ns | ||
35 | 67.03 (10) | 61.12 (10) ns | 28.80 (10) | 31.64 (10) ns | 10.65 (8) | 11.19 (9) ns | ||
38 | 68.52 (10) | 63.41 (10) ns | 28.22 (10) | 31.29 (10) ns | 10.44 (8) | 11.75 (8) ns | ||
42 | 70.10 (10) | 61.24 (10) ns | 24.61 (10) | 25.86 (10) ns | 10.73 (8) | 11.65 (8) ns |